Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 04/02/2019
Entire Document
 


Case 18-10518-KG     Doc 1006    Filed 03/29/19     Page 5 of 11

 

In re: Orexigen Therapeutics, Inc.

   Case No. 18-10518 (KG)

Debtor

   Reporting Period: February 1, 2019 - February 28, 2019

 

MOR - 1a

Schedule of Disbursements by Debtor Entity (1)

For the Period: February 1, 2019 - February 28, 2019

(Unaudited)

 

 $ USD ‘000s

 Debtor

   February 1, 2019 - February 28, 2019      Cumulative 
Since Filing 

 

 

 Orexigen Therapeutics, Inc.

            $                                 648        $         138,641  
    

 

 

 

  

 

 

 

 Total

       $ 648        $ 138,641  

 

    

 

  

 

 Notes:

 

 (1) The Schedule of Disbursements is presented on a book basis.